The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Plasma Choline Metabolites and Colorectal Cancer Risk in the Women's Health Initiative Observational Study
Open accessPublished version of a preprint
Abstract
Few studies have examined associations between plasma choline metabolites and risk of colorectal cancer. Therefore, we investigated associations between plasma biomarkers of choline metabolism [choline, betaine, dimethylglycine, and trimethylamine N-oxide (TMAO)] and colorectal cancer risk among postmenopausal women in a case–control study nested within the Women's Health Initiative Observational Study. We selected 835 matched case–control pairs, and cases were further stratified by tumor site (proximal, distal, or rectal) and stage (local/regional or metastatic). Colorectal cancer was assessed by self-report and confirmed by medical records over the mean of 5.2 years of follow-up. Baseline plasma choline metabolites were measured by LC/MS-MS. In multivariable-adjusted conditional logistic regression models, plasma choline tended to be positively associated with rectal cancer risk [OR (95% confidence interval, CI)highest vs. lowest quartile = 2.44 (0.93–6.40); P trend = 0.08], whereas plasma betaine was inversely associated with colorectal cancer overall [0.68 (0.47–0.99); P trend = 0.01] and with local/regional tumors [0.64 (0.42–0.99); P trend = 0.009]. Notably, the plasma betaine:choline ratio was inversely associated with colorectal cancer overall [0.56 (0.39–0.82); P trend = 0.004] as well as with proximal [0.66 (0.41–1.06); P trend = 0.049], rectal [0.27 (0.10–0.78); P trend = 0.02], and local/regional [0.50 (0.33–0.76); P trend = 0.001] tumors. Finally, plasma TMAO, an oxidative derivative of choline produced by intestinal bacteria, was positively associated with rectal cancer [3.38 (1.25–9.16); P trend = 0.02] and with overall colorectal cancer risk among women with lower (vs. higher) plasma vitamin B12 levels (P interaction = 0.003). Collectively, these data suggest that alterations in choline metabolism, which may arise early in disease development, may be associated with higher risk of colorectal cancer. The positive association between plasma TMAO and colorectal cancer risk is consistent with an involvement of the gut microbiome in colorectal cancer pathogenesis. Cancer Res; 74(24); 7442–52. ©2014 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent human studies have established that the levels of TMAO in serum are positively correlated with impaired renal function, colorectal cancer, and cardiovascular disease (CVD) (8, 10, 17, 18).”
From Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine- N -Oxide (2015) · cites this paper as [18]
Experimental — accuracy not yet measuredIn the citing paper
“In support of this hypothesis, the association between plasma level of TMAO and risk of CRC was restricted to patients with low plasma levels of vitamin B12.151”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [151]
In the citing paper
“Some,147, 148 but not all,149–151 prospective studies have associated higher dietary and plasma levels of choline with increased risk of colorectal neoplasia.”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [151]
In the citing paper
“The Women's Health Initiative and the alpha-tocopherol, beta-carotene cancer prevention observational studies reported that alterations in choline metabolism and plasma TMAO concentrations were predicted risk factors for colorectal cancer (7,83).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [7]
In the citing paper
“Recent human studies have established that the levels of TMAO in serum are positively correlated with impaired renal function, colorectal cancer, and cardiovascular disease (CVD) (8, 10, 17, 18).”
From Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine- N -Oxide (2015) · cites this paper as [18]
In the citing paper
“Recent human studies have established that the levels of TMAO in serum are positively correlated with impaired renal function, colorectal cancer, and cardiovascular disease (CVD) (8, 10, 17, 18).”
From Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine- N -Oxide (2015) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Design of the Women’s Health Initiative Clinical Trial and Observational Study
The Women’s Health Initiative Study Group (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,580
Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
Haggar, F. A., & Boushey, R. P. (2009) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0029-1242458 · Cited by 2,018
Bacteria as vitamin suppliers to their host: A gut microbiota perspective
LeBlanc, J. G., Milani, C., de Giori, G. S., Sesma, F., van Sinderen, D., & Ventura, M. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.08.005 · Cited by 1,613 · cited 1×
“Certain groups of intestinal bacteria can synthesize (45, 46) and consume (47, 48) vitamin B12, 291 which may impact the vitamin B12 requirement/status of the host.”
Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's Role
Crider, K. S., Yang, T. P., Berry, R. J., & Bailey, L. B. (2012) · Advances in Nutrition · doi:10.3945/an.111.000992 · Cited by 1,055
Self-citationDumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601056103 · Cited by 1,042
Choline metabolism in malignant transformation
Glunde, K., Bhujwalla, Z. M., & Ronen, S. M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3162 · Cited by 826
Outcomes ascertainment and adjudication methods in the women's health initiative
Curb, J. D., McTiernan, A., Heckbert, S. R., Kooperberg, C. L., Stanford, J. L., Nevitt, M. C., Johnson, K., Proulx-Burns, L., Pastore, L. M., Criqui, M. H., et al. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00048-6 · Cited by 700
Research works printed but not linked: 1
- US Food and Drug Administration, 1996, Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final Rule. 21 CFR Parts 136, 137, and 139, Fed Regist, 61, 8781
Cited by
Sorted by citations
Thomas, A. M., Manghi, P., Asnicar, F., Pasolli, E., Armanini, F., Zolfo, M., Beghini, F., Manara, S., Karcher, N., Pozzi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0405-7 · Cited by 1,030
Self-citationInfluence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752
Romano, K. A., Vivas, E. I., Amador-Noguez, D., & Rey, F. E. (2015) · mBio · doi:10.1128/mbio.02481-14 · Cited by 777
Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health
Parker, A., Fonseca, S., & Carding, S. R. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1638722 · Cited by 745
Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease
Zeisel, S. H., & Warrier, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064732 · Cited by 475
Kerfeld, C. A., Aussignargues, C., Zarzycki, J., Cai, F., & Sutter, M. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2018.10 · Cited by 452
Cho, C. E., Taesuwan, S., Malysheva, O. V., Bender, E., Tulchinsky, N. F., Yan, J., Sutter, J. L., & Caudill, M. A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600324 · Cited by 405
Self-citationMirji, G., Worth, A., Bhat, S. A., El Sayed, M., Kannan, T., Goldman, A. R., Tang, H.-Y., Liu, Q., Auslander, N., Dang, C. V., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abn0704 · Cited by 327
TMAO: A small molecule of great expectations
Ufnal, M., Żądło‐Dobrowolska, A., & Ostaszewski, R. (2015) · Nutrition · doi:10.1016/j.nut.2015.05.006 · Cited by 327
Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
Qu, R., Zhang, Y., Ma, Y., Zhou, X., Sun, L., Jiang, C., Zhang, Z., & Fu, W. (2023) · Advanced Science · doi:10.1002/advs.202205563 · Cited by 314
Dysbiosis of gut microbiota in promoting the development of colorectal cancer
Zou, S., Fang, L., & Lee, M. (2017) · Gastroenterology report · doi:10.1093/gastro/gox031 · Cited by 283
Genetic Factors Are Not the Major Causes of Chronic Diseases
Rappaport, S. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154387 · Cited by 259
Gut microbiota: A target for heavy metal toxicity and a probiotic protective strategy
Duan, H., Yu, L., Tian, F., Zhai, Q., Fan, L., & Chen, W. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140429 · Cited by 253
Martínez-del Campo, A., Bodea, S., Hamer, H. A., Marks, J. A., Haiser, H. J., Turnbaugh, P. J., & Balskus, E. P. (2015) · mBio · doi:10.1128/mbio.00042-15 · Cited by 224
Trimethylamine- N -Oxide: Friend, Foe, or Simply Caught in the Cross-Fire?
Cho, C. E., & Caudill, M. A. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.10.005 · Cited by 220
Self-citationMueller, D. M., Allenspach, M., Othman, A., Saely, C. H., Muendlein, A., Vonbank, A., Drexel, H., & von Eckardstein, A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.091 · Cited by 217
Rohrmann, S., Linseisen, J., Allenspach, M., von Eckardstein, A., & Müller, D. (2016) · The Journal of Nutrition · doi:10.3945/jn.115.220103 · Cited by 197
Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells
Saito, R. D. F., Andrade, L. N. D. S., Bustos, S. O., & Chammas, R. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.768606 · Cited by 190
Li, D., Lu, Y., Yuan, S., Cai, X., He, Y., Chen, J., Wu, Q., He, D., Fang, A., Bo, Y., et al. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac074 · Cited by 193
Mondul, A. M., Moore, S. C., Weinstein, S. J., Karoly, E. D., Sampson, J. N., & Albanes, D. (2015) · International Journal of Cancer · doi:10.1002/ijc.29576 · Cited by 179
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid
Del Rio, D., Zimetti, F., Caffarra, P., Tassotti, M., Bernini, F., Brighenti, F., Zini, A., & Zanotti, I. (2017) · Nutrients · doi:10.3390/nu9101053 · Cited by 172
“Similarly, it has been associated with other chronic diseases, such as diabetes [10] and cancer [11], further strengthening the pathological implications of this microbiota metabolite.”
BackgroundFu, B. C., Hullar, M. A. J., Randolph, T. W., Franke, A. A., Monroe, K. R., Cheng, I. C., Wilkens, L. R., Shepherd, J., Madeleine, M. M., Marchand, L. L., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa015 · Cited by 177
Trimethylamine N‐oxide: breathe new life
Subramaniam, S., & Fletcher, C. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13959 · Cited by 171
Bekhit, A. E. A., Giteru, S. G., Holman, B. W. B., & Hopkins, D. L. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12764 · Cited by 170
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 171
Choline metabolism-based molecular diagnosis of cancer: an update
Glunde, K., Penet, M., Jiang, L., Jacobs, M. A., & Bhujwalla, Z. M. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1039515 · Cited by 163
Alisson-Silva, F., Kawanishi, K., & Varki, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.07.002 · Cited by 156
Wu, J., Wen, X., Faulk, C. D., Boehnke, K. F., Zhang, H., Dolinoy, D. C., & Xi, C. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw046 · Cited by 153
Trimethylamine N-Oxide in Relation to Cardiometabolic Health—Cause or Effect?
Papandreou, C., Moré, M. I., & Bellamine, A. (2020) · Nutrients · doi:10.3390/nu12051330 · Cited by 157
Tsiaoussis, J., Antoniou, M. N., Koliarakis, I., Mesnage, R., Vardavas, C. I., Izotov, B. N., Psaroulaki, A., & Tsatsakis, A. M. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.04.014 · Cited by 139
Bist, P., & Choudhary, S. (2022) · Biological Trace Element Research · doi:10.1007/s12011-021-03092-4 · Cited by 135
Trimethylamine N -oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
Nowiński, A., & Ufnal, M. (2017) · Nutrition · doi:10.1016/j.nut.2017.08.001 · Cited by 132
Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota
Loke, Y. L., Chew, M. T., Ngeow, Y. F., Lim, W. W.-D., & Peh, S. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.603086 · Cited by 138
Milk Polar Lipids: Underappreciated Lipids with Emerging Health Benefits
Anto, L., Warykas, S. W., Torres‐Gonzalez, M., & Blesso, C. N. (2020) · Nutrients · doi:10.3390/nu12041001 · Cited by 119
Sánchez‐Alcoholado, L., Ordóñez, R., Otero, A. P., Plaza-Andrades, I. J., Laborda-Illanes, A., Medina, J. A., Ramos‐Molina, B., Gómez‐Millán, J., & Queipo‐Ortuño, M. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186782 · Cited by 120
Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges
Zhang, W., An, Y., Qin, X., Wu, X., Wang, X., Hou, H., Song, X., Liu, T., Wang, B., Huang, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.739648 · Cited by 122
The roles of microbial products in the development of colorectal cancer: a review
Fang, Y., Yan, C., Zhao, Q., Xu, J., Liu, Z., Gao, J., Zhu, H., Dai, Z., Wang, D., & Tang, D. (2021) · Bioengineered · doi:10.1080/21655979.2021.1889109 · Cited by 122
Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year
Kühn, T., Rohrmann, S., Sookthai, D., Johnson, T., Katzke, V., Kaaks, R., von Eckardstein, A., & Müller, D. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0374 · Cited by 110
Gut microbiota-derived metabolites in CRC progression and causation
Dalal, N., Jalandra, R., Bayal, N., Yadav, A. K., Harshulika, Sharma, M., Makharia, G. K., Kumar, P., Singh, R. K., Solanki, P. R., et al. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03729-w · Cited by 105
Millard, H. R., Musani, S. K., Dibaba, D. T., Talegawkar, S. A., Taylor, H. A., Tucker, K. L., & Bidulescu, A. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1296-8 · Cited by 101
Chan, C. W. H., Law, B. M. H., Waye, M. M. Y., Chan, J. Y., So, W. K. W., & Chow, K. M. (2019) · Journal of Cancer · doi:10.7150/jca.31737 · Cited by 96
Guertin, K. A., Li, X. S., Graubard, B. I., Albanes, D., Weinstein, S. J., Goedert, J. J., Wang, Z., Hazen, S. L., & Sinha, R. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0948 · Cited by 96
Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer
Jalandra, R., Dalal, N., Yadav, A. K., Verma, D., Sharma, M., Singh, R. K., Khosla, A., Kumar, A., & Solanki, P. R. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11582-7 · Cited by 258
Toxic and essential metals: metabolic interactions with the gut microbiota and health implications
Zhu, Q., Chen, B., Zhang, F., Zhang, B., Guo, Y., Pang, M., Huang, L., & Wang, T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1448388 · Cited by 101
The complex metabolism of trimethylamine in humans: endogenous and exogenous sources
Chhibber-Goel, J., Gaur, A., Singhal, V., Parakh, N., Bhargava, B., & Sharma, A. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2016.6 · Cited by 93
Tocchetti, C. G., Ameri, P., de Boer, R. A., D’Alessandra, Y., Russo, M., Sorriento, D., Ciccarelli, M., Kiss, B., Bertrand, L., Dawson, D. K., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa222 · Cited by 94
Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases
Constantino-Jonapa, L. A., Espinoza-Palacios, Y., Escalona‐Montaño, A. R., Hernández-Ruiz, P., Amezcua-Guerra, L. M., Amedei, A., & Aguirre‐García, M. M. (2023) · Biomedicines · doi:10.3390/biomedicines11020431 · Cited by 99
Gurwara, S., Ajami, N. J., Jang, A., Hessel, F. C., Chen, L., Plew, S., Wang, Z., Graham, D. Y., Hair, C. D., White, D. L., et al. (2019) · Nutrients · doi:10.3390/nu11030613 · Cited by 91
Zhou, Y., Zhang, Y., Jin, S., Lv, J., Li, M., & Feng, N. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117031 · Cited by 94
Ocvirk, S., Wilson, A. S., Posma, J. M., Li, J. V., Koller, K. R., Day, G. M., Flanagan, C. A., Otto, E., Sacco, P. E., Sacco, F. D., et al. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz301 · Cited by 84
Trimethylamine N-Oxide Promotes Cell Proliferation and Angiogenesis in Colorectal Cancer
Yang, S., Dai, H., Lu, Y., Li, R., Gao, C., & Pan, S. (2022) · Journal of Immunology Research · doi:10.1155/2022/7043856 · Cited by 86
Modesitt, S. C., Hallowell, P. T., Slack‐Davis, J. K., Michalek, R. D., Atkins, K. A., Kelley, S. L., Arapovic, S., Shupnik, M. A., & Hoehn, K. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.05.015 · Cited by 81
Pb Toxicity on Gut Physiology and Microbiota
Liu, W., Feng, H., Zheng, S., Xu, S., Massey, I. Y., Zhang, C., Wang, X., & Yang, F. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.574913 · Cited by 83
Microbial metabolites in colorectal tumorigenesis and cancer therapy
Liu, Y., Lau, H. C.-H., & Yu, J. Q. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2203968 · Cited by 84
Griffin, L. E., Djurić, Z., Angiletta, C. J., Mitchell, C. M., Baugh, M. E., Davy, K. P., & Neilson, A. P. (2019) · Food & Function · doi:10.1039/c9fo00333a · Cited by 78
Schugar, R. C., Gliniak, C. M., Osborn, L. J., Massey, W. J., Sangwan, N., Horak, A. J., Banerjee, R., Orabi, D., Helsley, R. N., Brown, A. L., et al. (2022) · eLife · doi:10.7554/elife.63998 · Cited by 75
Gut Microbiota-Derived Metabolite Trimethylamine N-Oxide as a Biomarker in Early Parkinson’s Disease
Chung, S. J., Rim, J. H., Ji, D., Lee, S., Yoo, H. S., Jung, J. H., Baik, K., Choi, Y., Ye, B. S., Sohn, Y. H., et al. (2021) · Nutrition · doi:10.1016/j.nut.2020.111090 · Cited by 74
Rombouts, C., Hemeryck, L., HECKE, T. V., SMET, S. D., Vos, W. H. D., & Vanhaecke, L. (2017) · Scientific Reports · doi:10.1038/srep42514 · Cited by 74
Changes in gut microbiota composition after bariatric surgery: a new balance to decode
Palmisano, S., Campisciano, G., Silvestri, M., Guerra, M., Giuricin, M., Casagranda, B., Comar, M., & de Manzini, N. (2020) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04321-x · Cited by 72
Ilyas, A., Wijayasinghe, Y. S., Khan, I., Samaloty, N. M. E., Adnan, M., Dar, T. A., Poddar, N. K., Singh, L. R., Sharma, H., & Khan, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.964624 · Cited by 73
Yu, H., Geng, W., Zheng, Z., Gao, J., Guo, D., & Wang, Y. (2019) · Theranostics · doi:10.7150/thno.33459 · Cited by 68
Prospective study of blood metabolites associated with colorectal cancer risk
Shu, X., Xiang, Y., Rothman, N., Yu, D., Li, H., Yang, G., Cai, H., Ma, X., Qing Lan, B., Gao, Y., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31341 · Cited by 67
Preoperative Serum TMAO Level is a New Prognostic Marker for Colorectal Cancer
Liu, X., Liu, H., Yuan, C., Zhang, Y., Wang, W., Hu, S., Liu, L., & Wang, Y. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0262 · Cited by 67
Reichard, C. A., Naelitz, B. D., Wang, Z., Jia, X., Li, J., Stampfer, M. J., Klein, E. A., Hazen, S. L., & Sharifi, N. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0766 · Cited by 64
Roe, A. J., Zhang, S., Bhadelia, R. A., Johnson, E. J., Lichtenstein, A. H., Rogers, G. T., Rosenberg, I. H., Smith, C. E., Zeisel, S. H., & Scott, T. M. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.137158 · Cited by 64
Liu, Z., Tan, X., Li, Q., Liao, G., Fang, A., Zhang, D., Chen, P., Wang, X., Luo, Y., Long, J., et al. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0319-2 · Cited by 67
Balancing the Equation: A Natural History of Trimethylamine and Trimethylamine-N-oxide
Loo, R. L., Chan, Q. M., Nicholson, J. K., & Holmes, E. C. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00851 · Cited by 63
Metabolomic epidemiology offers insights into disease aetiology
Fuller, H., Zhu, Y., Nicholas, J. C., Chatelaine, H., Drzymalla, E., Sarvestani, A. K., Julián‐Serrano, S., Tahir, U. A., Sinnott-Armstrong, N., Raffield, L. M., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00903-x · Cited by 63
Garcia, E., Wolak, J. E., Wang, Z., Li, X. S., Bennett, D. W., Connelly, M. A., Otvos, J. D., Hazen, S. L., & Jeyarajah, E. J. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.06.003 · Cited by 62
The metabolic fate of isotopically labeled trimethylamine-N-oxide (TMAO) in humans
Taesuwan, S., Cho, C. E., Malysheva, O. V., Bender, E., King, J. H., Yan, J., Thalacker-Mercer, A. E., & Caudill, M. A. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.010 · Cited by 62
Self-citationTacconi, E., Palma, G., Biase, D. D., Luciano, A., Barbieri, M., de Nigris, F., & Bruzzese, F. (2023) · Nutrients · doi:10.3390/nu15030563 · Cited by 62
A Bacterial Microcompartment Is Used for Choline Fermentation by Escherichia coli 536
Herring, T. I., Harris, T. N., Chowdhury, C., Mohanty, S. K., & Bobik, T. A. (2018) · Journal of Bacteriology · doi:10.1128/jb.00764-17 · Cited by 61
Association of choline and betaine levels with cancer incidence and survival: A meta-analysis
Youn, J., Cho, E., & Lee, J. E. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.01.042 · Cited by 58
Ungvari, Z., Fekete, M., Varga, P., Lehoczki, A., Munkácsy, G., Fekete, J. T., Bianchini, G., Ocana, A., Buda, A., Ungvari, A., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01646-1 · Cited by 56
Microbial Metabolite Dysbiosis and Colorectal Cancer
Niekamp, P., & Kim, C. H. (2023) · Gut and Liver · doi:10.5009/gnl220260 · Cited by 60
Huang, J., Weinstein, S. J., Moore, S. C., Derkach, A., Hua, X., Liao, L. M., Gu, F., Mondul, A. M., Sampson, J. N., & Albanes, D. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy017 · Cited by 52
Microbiota of the gastrointestinal tract: Friend or foe?
Senchukova, M. A. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i1.19 · Cited by 56
Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies
de Wit, S., Glen, C., de Boer, R. A., & Lang, N. N. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac132 · Cited by 54
Ottiger, M., Nickler, M., Steuer, C., Odermatt, J., Huber, A., Christ‐Crain, M., Henzen, C., Hoess, C., Thomann, R., Zimmerli, W., et al. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.08.017 · Cited by 50
Redefining environmental exposure for disease etiology
Rappaport, S. M. (2018) · npj Systems Biology and Applications · doi:10.1038/s41540-018-0065-0 · Cited by 49
Mola, S., Pandolfo, C., Sica, A., & Porta, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186866 · Cited by 48
Raj, V., Bhadauria, A. S., Singh, A. K., Kumar, U., Rai, A., Keshari, A. K., Kumar, P., Kumar, D., Maity, B., Nath, S., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2018.03.026 · Cited by 45
Folate and choline absorption and uptake: Their role in fetal development
Radziejewska, A., & Chmurzyńska, A. (2018) · Biochimie · doi:10.1016/j.biochi.2018.12.002 · Cited by 48
Wang, Q., & Xu, R. (2019) · BMC Genomics · doi:10.1186/s12864-019-5510-y · Cited by 46
The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy
Situ, Y., Zhang, P., Zhang, C., Jiang, A., Zhang, N., Zhu, L., Mou, W., Liu, Z., Wong, H. Z. H., Zhang, J., et al. (2025) · eBioMedicine · doi:10.1016/j.ebiom.2025.105708 · Cited by 45
Advances in the World of Bacterial Microcompartments
Stewart, A. M., Stewart, K. L., Yeates, T. O., & Bobik, T. A. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.12.002 · Cited by 43
Mahmud, I., Pinto, F. G., Rubio, V. Y., Lee, B., Pavlovich, C. P., Perera, R. J., & Garrett, T. J. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00943 · Cited by 44
Wu, Y., Rong, X., Pan, M., Wang, T., Yang, H., Chen, X., Xiao, Z., & Zhao, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.840171 · Cited by 42
Shi, C., de Wit, S., Učambarlić, E., Markousis‐Mavrogenis, G., Screever, E. M., Meijers, W. C., de Boer, R. A., & Aboumsallem, J. P. (2023) · Cancers · doi:10.3390/cancers15030729 · Cited by 51
De-coding the complex role of microbial metabolites in cancer
Escriva, P. P., Bernardino, C. C. T., & Letellier, E. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115358 · Cited by 48
Heaney, L. M., Jones, D. J. L., Mbasu, R. J., Ng, L. L., & Suzuki, T. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-9164-6 · Cited by 41
Enalapril decreases rat plasma concentration of TMAO, a gut bacteria-derived cardiovascular marker
Konop, M., Radkowski, M., Grochowska, M., Perlejewski, K., Samborowska, E., & Ufnal, M. (2018) · Biomarkers · doi:10.1080/1354750x.2018.1432689 · Cited by 46
Cheng, T. D., Makar, K. W., Neuhouser, M. L., Miller, J. W., Song, X., Brown, E. C., Beresford, S. A. A., Zheng, Y., Poole, E. M., Galbraith, R. L., et al. (2015) · Cancer · doi:10.1002/cncr.29465 · Cited by 40
Self-citationNeveu, V., Nicolas, G., Amara, A., Salek, R. M., & Scalbert, A. (2023) · Scientific Reports · doi:10.1038/s41598-022-26366-w · Cited by 41
Choline metabolism and its implications in cancer
Yao, N., Li, W., Xu, G., Duan, N., Yu, G., & Qu, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1234887 · Cited by 44
Intestinal Macrophages at the Crossroad between Diet, Inflammation, and Cancer
Caprara, G., Allavena, P., & Erreni, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144825 · Cited by 38
Nutrigenomics at the Interface of Aging, Lifespan, and Cancer Prevention
Riscuta, G. (2016) · The Journal of Nutrition · doi:10.3945/jn.116.235119 · Cited by 37
Wang, Q., Huang, H., Yang, Y., Yang, X., Li, X., Zhong, W., Wen, B., He, F., & Li, J. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1491821 · Cited by 51
Huang, J. Y., Luu, H. N., Butler, L. M., Midttun, Ø., Ulvik, A., Wang, R., Jin, A., Gao, Y., Tan, Y., Ueland, P. M., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32994 · Cited by 36
Cys34 Adductomics Links Colorectal Cancer with the Gut Microbiota and Redox Biology
Grigoryan, H., Schiffman, C., Gunter, M. J., Naccarati, A., Polidoro, S., Dagnino, S., Dudoit, S., Vineis, P., & Rappaport, S. M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1529 · Cited by 37
Metadata
- Authors
- Bae, S., Ulrich, C. M., Neuhouser, M. L., Malysheva, O., Bailey, L. B., Xiao, L., Brown, E. C., Cushing-Haugen, K. L., Zheng, Y., Cheng, T.-Y. D., Miller, J. W., Green, R., Lane, D. S., Beresford, S. A. A., & Caudill, M. A.
- Affiliations
- Cornell University (US)
- German Cancer Research Center (DE)
- Fred Hutch Cancer Center (US)
- University of Georgia (US)
- 2Fred Hutchinson Cancer Research Center, Seattle, Washington.
- Rutgers, The State University of New Jersey (US)
- University of California, Davis (US)
- Stony Brook School (US)
- Corresponding author
- Ulrich, Cornelia M.
- Caudill, Marie A.
- ORCID
- Venue
- Cancer Research
- Published
- 2014-12-14
- Volume
- 74
- Issue
- 24
- Pages
- 7442-7452
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC4268282
- OpenAlex
- W2092436074
- Cited by
- 253
- References
- 56
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 27 · 2023: 34 · 2022: 23 · 2021: 34 · 2020: 24 · 2019: 20 · 2018: 19 · 2017: 17 · 2016: 16 · 2015: 13
- FWCI
- 15.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health (HHSN268201100004C, n01wh22110-38-0-0, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, N01 WH022110)
- National Institute on Aging (HHSN-271-2011-00004C,)
- National Heart, Lung, and Blood Institute (HHSN2682011-00001I, HHSN2682011-00002I, HHSN2682011‐00004I, HHSN268201100046C, HHSN2682011-00003I)
- National Cancer Institute (R01CA120523)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- colorectal cancer risk, choline metabolism, plasma choline, betaine, dimethylglycine, trimethylamine N-oxide, rectal cancer, postmenopausal women, vitamin B12, tumor location, tumor stage, plasma biomarkers, Women's Health Initiative Observational Study, gut microbiota, oxidative stress, inflammation
- MeSH terms
- Aged, Betaine, Choline, Female, Humans, Methylamines, Middle Aged, Risk Factors, Colorectal Neoplasms, Women's Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
